Semex Nyheder

Three years after the launch of Immunity+ sires, dairymen worldwide are reaping the benefits of Semex’s exclusive technology.

Developed by Dr. Bonnie Mallard and her colleagues at the University of Guelph, the research surrounding the HIR (High Immune Response) technology that Immunity+ is based on spans decades, includes over 100 published papers and is 30% heritable.

“No other product or solution available has this, or is 30% heritable with immediate effects… This starts at birth, there’s no wait,” says Paul Krueger, Semex Immunity+ Global Brand Manager. “We hear every day how dairymen are benefitting from this technology.”

“When Semex asked me to start tracking our calf care and treatments, those calves that didn’t get sick were always Immunity+ calves,” comments Nate Bennet, Herdsman at Schwab Dairy Farm, a 1,000-cow dairy in Delevan, NY. “During the winter, our heifer pens in the pack barn can be up to 50% overcrowded. In the last year, we’ve only treated three heifers for pneumonia, a huge decrease from years past.”

In December 2015 Semex has:

• 63 Genomax Immunity+ bulls over +2300 GTPI


• 48 Genomax Immunity+ bulls over +2400 GTPI


• 12 Genomax Immunity+ bulls over +2500 GTPI


• Two new Jersey Immunity+ bulls:
  
  
  
  • 0200JE00193 Buttercrest Standing
  
  
  • 0200JE00180 Ertl Mantra
  
  
  
  

For more information on Semex, Genetics for Life, Immunity+, Genomax sires or any of Semex’s brands visit: www.semex.com